| Date Filed | Type | Description |
| 02/20/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 02/14/2020 |
SC 13G/A
| Hagerman Philip R reports a 22.8% stake in Diplomat Pharmacy, Inc. |
| 02/14/2020 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in Diplomat Pharmacy, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/10/2020 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 02/10/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 02/10/2020 |
8-K
| Quarterly results |
| 02/07/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/07/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/04/2020 |
SC 13G/A
| BlackRock Inc. reports a 12.3% stake in DIPLOMAT PHARMACY INC |
| 01/29/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/29/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 01/21/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/09/2020 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 01/09/2020 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 12/30/2019 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/30/2019 |
8-K
| Quarterly results |
| 12/19/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 12/10/2019 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/10/2019 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 12/09/2019 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 12/09/2019 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/09/2019 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 11/21/2019 |
SC 13G
| MORGAN STANLEY reports a 6.6% stake in Diplomat Pharmacy, Inc. |
| 11/12/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 11/12/2019 |
8-K
| Quarterly results |
| 11/08/2019 |
SC 13G/A
| Capital World Investors reports a 2.7% stake in Diplomat Pharmacy, Inc. |
| 08/26/2019 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5.7% stake in Diplomat Pharmacy, Inc. |
| 08/09/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
| 08/09/2019 |
8-K
| Quarterly results, Credit agreement amendment|
Docs:
|
"Amendment No. 1 to Credit Agreement, by and among the Company, the Lenders and JPMorgan Chase Bank, N.A., as Administrative Agent, effective August 6, 2019",
"Diplomat Announces 2nd Quarter Financial Results Updates 2019 Guidance",
"Supplemental slide presentation for the quarter ended June 30, 2019",
"###" |
|
|